Wealth Architects’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
5,655
-106
-2% -$6.09K 0.03% 181
2026
Q1
$349K Sell
5,761
-75
-1% -$4.37K 0.03% 166
2025
Q4
$315K Sell
5,836
-37
-0.6% -$1.78K 0.03% 177
2025
Q3
$265K Sell
5,873
-304
-5% -$14.2K 0.03% 191
2025
Q2
$286K Buy
6,177
+146
+2% +$7.17K 0.03% 175
2025
Q1
$368K Buy
6,031
+66
+1% +$3.85K 0.04% 159
2024
Q4
$337K Buy
5,965
+302
+5% +$16.9K 0.04% 156
2024
Q3
$293K Sell
5,663
-255
-4% -$12K 0.03% 167
2024
Q2
$246K Sell
5,918
-459
-7% -$20.5K 0.03% 179
2024
Q1
$346K Sell
6,377
-188
-3% -$9.58K 0.05% 150
2023
Q4
$337K Sell
6,565
-1,722
-21% -$90.4K 0.05% 141
2023
Q3
$481K Buy
8,287
+275
+3% +$16.9K 0.08% 111
2023
Q2
$512K Buy
8,012
+366
+5% +$24.5K 0.08% 110
2023
Q1
$530K Buy
7,646
+233
+3% +$16.4K 0.09% 98
2022
Q4
$533K Buy
7,413
+19
+0.3% +$1.43K 0.1% 91
2022
Q3
$526K Sell
7,394
-881
-11% -$63.9K 0.11% 85
2022
Q2
$637K Buy
8,275
+245
+3% +$18.7K 0.12% 77
2022
Q1
$586K Sell
8,030
-374
-4% -$25.1K 0.1% 94
2021
Q4
$524K Sell
8,404
-627
-7% -$36.8K 0.09% 105
2021
Q3
$534K Buy
9,031
+394
+5% +$25.9K 0.1% 94
2021
Q2
$577K Buy
8,637
+610
+8% +$39.8K 0.11% 81
2021
Q1
$507K Buy
8,027
+236
+3% +$14.7K 0.11% 83
2020
Q4
$483K Buy
7,791
+315
+4% +$19.4K 0.11% 80
2020
Q3
$451K Buy
7,476
+64
+0.9% +$3.85K 0.12% 76
2020
Q2
$436K Sell
7,412
-4
-0.1% -$239 0.12% 76
2020
Q1
$413K Buy
7,416
+542
+8% +$33.1K 0.14% 73
2019
Q4
$441K Buy
6,874
+109
+2% +$6.24K 0.12% 75
2019
Q3
$343K Buy
6,765
+85
+1% +$4K 0.1% 88
2019
Q2
$303K Buy
6,680
+394
+6% +$18.4K 0.09% 93
2019
Q1
$300K Buy
6,286
+177
+3% +$8.82K 0.09% 90
2018
Q4
$318K Sell
6,109
-814
-12% -$43.7K 0.11% 82
2018
Q3
$430K Buy
6,923
+848
+14% +$50.3K 0.13% 68
2018
Q2
$336K Sell
6,075
-73
-1% -$3.94K 0.11% 78
2018
Q1
$389K Hold
6,148
0.13% 68
2017
Q4
$377K Sell
6,148
-278
-4% -$17.4K 0.12% 78
2017
Q3
$410K Sell
6,426
-161
-2% -$9.4K 0.14% 73
2017
Q2
$367K Sell
6,587
-406
-6% -$22.1K 0.14% 78
2017
Q1
$380K Buy
6,993
+56
+0.8% +$3.07K 0.15% 73
2016
Q4
$405K Buy
6,937
+27
+0.4% +$1.48K 0.18% 69
2016
Q3
$372K Sell
6,910
-190
-3% -$12.2K 0.17% 73
2016
Q2
$522K Sell
7,100
-132
-2% -$9.33K 0.25% 57
2016
Q1
$462K Sell
7,232
-222
-3% -$14K 0.23% 60
2015
Q4
$513K Sell
7,454
-400
-5% -$26.4K 0.25% 60
2015
Q3
$465K Sell
7,854
-430
-5% -$27.3K 0.25% 60
2015
Q2
$551K Hold
8,284
0.3% 52
2015
Q1
$534K Buy
8,284
+300
+4% +$18.8K 0.31% 46
2014
Q4
$471K Buy
+7,984
New +$450K 0.28% 51

Other funds holding BMY

Wealth Architects's BMY Position: Q2 2026 in Review

Wealth Architects reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q2 2026, selling an estimated $6.09K and leaving 5,655 shares worth $326K. The position accounts for 0.03% of the portfolio, ranked #181.

Wealth Architects first reported a position in BMY in Q4 2014 and has held it in 47 quarters since. The position peaked at $637K in Q2 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wealth Architects held 5,655 shares of Bristol-Myers Squibb worth $326K as of Q2 2026.
  • Wealth Architects sold 106 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.09K.
  • Bristol-Myers Squibb made up 0.03% of Wealth Architects's portfolio in Q2 2026, its #181 holding.
  • Wealth Architects first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 47 quarters since.
  • Wealth Architects's Bristol-Myers Squibb position peaked at $637K in Q2 2022.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wealth Architects's 13F filing for Q2 2026, filed 23 Jul 2026.